EN DE ES FR IT Primary Menu Introduction to moderate sedation Procedural Burden Pain and/or Fear and/or Anticipatory Anxiety Pre-medication Emergency MRI, CT scans Fibroscopy, Endoscopy Dental Anxiety Needles Catheters Gas mask Surgery Painful Fractures Sutures Burns Painless Claustrophic Unmoving conditions Endoscopy Fearful conditions Unpleasant procedures Dental Needles Drills Stressful procedures The formulation was developed at the Amiens Hospital in France, with the help of an Anaesthesiologist and a Hospital Pharmacist. Innovation – OZALIN® / OZASED® Launch OZALIN®*as an oral paediatric sedative licensed and approved in EU. Launching in 2020-2022 across EU. Utilising a mix or Primex own teams and partners across EU. Expand with the submission of regulatory files for international markets. *OZALIN® / OZASED® is indicated in infants (from 6 months), children and adolescents, for moderate sedation before a therapeutic or diagnostic procedure to relieve anxiety, distress and agitation related to the procedure or as premedication before anaesthesia. Collaborations http://www.safetots.org (Supported by an unrestricted educational grant from Primex Pharmaceuticals) Safetots.org is a non-profit initiative of leading paediatric anaesthesiologists. We promote safe conduct of anaesthesia in children. http://troops-sedation.com (Supported by an educational grant from Primex Pharmaceuticals) A standardized quality improvement tool from the International Committee for the Advancement of Procedural Sedation. TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy

EN DE ES FR IT Primary Menu Contact General inquiries: Tel. +41 41 720 2000 info@primexpharma.com Drug safety: Report adverse event Medical information: product related questions medicalinfo@primexpharma.com Find us in LinkedIn: Location in Zug, Switzerland Addresses Primex Pharmaceuticals AG Reiffergässli 3 CH-6300 Zug Switzerland Primex Pharmaceuticals Ltd. Mannerheimintie 12 B 5th floor 00100 Helsinki Finland Location in Helsinki, Finland OGNA Giovanni Ogna e Figli S.r.l Via Figini, 41 20835 Muggiò, Monza, MB Italy Visit OGNA website: http://new.ognalaboratori.it/company/ Location in Monza, Italy TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy